Want to join the conversation?
$CAH's Pharmaceutical segment continued its momentum into 1Q16, and the Medical segment strengthened its position in strategically critical areas. On a YoverY basis, Pharmaceutical segment posted 1Q16 revenue growth of 19% on growth from existing and new customers while Medical segment revenue grew marginally by 2%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?